CAR T-cell therapy: Reprogramming the immune system to treat cancer | Rob Weinkove | TEDxTauranga

TEDx Talks2 minutes read

The speaker's father established a weight loss clinic, leading the speaker to pursue medicine to reduce the impact of illnesses and transition to immunology research. CAR T cell therapy, reprogramming T cells to fight cancer, shows promise in treating blood cancers and addressing healthcare disparities through clinical trials for widespread implementation.

Insights

  • The speaker's father, Cyril, founded a successful weight loss clinic, setting the foundation for the speaker's medical aspirations focused on improving quality of life through illness management.
  • Immunotherapies such as CAR T cell therapy show promise in treating resistant blood cancers, highlighting the importance of expanding access through training, regulations, and equitable treatment availability to revolutionize cancer care and enhance patient well-being.

Get key ideas from YouTube videos. It’s free

Recent questions

  • What is CAR T cell therapy?

    CAR T cell therapy involves reprogramming T cells to target cancer cells.

  • How do bone marrow transplants work?

    Bone marrow transplants treat blood cancers but can have side effects.

  • What role do B and T cells play in the immune system?

    B and T cells are crucial for fighting infections and detecting mutations.

  • What challenges are faced in making CAR T cell therapy widely available?

    Challenges include training clinicians, establishing regulations, and ensuring equitable access.

  • How can clinical trials outside major cities help address healthcare disparities?

    Trials outside major cities can support innovative treatments and improve access to care.

Related videos

Summary

00:00

"Advancements in CAR T Cell Therapy"

  • The speaker's father, Cyril, established a successful weight loss clinic at Hope Hospital in England.
  • The speaker's work in medicine aims to reduce the impact of illnesses, allowing more time for enjoyable activities.
  • The speaker transitioned from being a junior doctor to an immunology researcher at the Mulligan Institute.
  • Bone marrow transplants, used in treating blood cancers, can have severe side effects.
  • Two patients, John and Sarah, had different outcomes after bone marrow transplants for their cancers.
  • The immune system, particularly B and T cells, plays a crucial role in fighting infections and detecting mutations that could lead to cancer.
  • Immunotherapies, like CAR T cell therapy, reprogram T cells to target and destroy cancer cells.
  • CAR T cells are created by modifying a patient's T cells with a new gene encoding a chimeric antigen receptor.
  • CAR T cell therapy has shown promising results in treating blood cancers, even in patients resistant to other treatments.
  • To make CAR T cell therapy more widely available, clinicians need training, regulations must be established, and access to treatment should be equitable.

16:32

Rural Clinical Trials Advance Cancer Treatment Access

  • Clinical trials outside major cities aim to address healthcare disparities, requiring support for logistical, regulatory, and cost challenges; these trials pave the way for widespread implementation of innovative treatments like immunotherapy, offering hope for more effective cancer therapies and a future with reduced hospital visits and increased well-being.
Channel avatarChannel avatarChannel avatarChannel avatarChannel avatar

Try it yourself — It’s free.